G. Ricci, F. Torri, F. Bianchi, L. Fontanelli, E. Schirinzi, Elisa Gualdani, P. Francesconi, Delia Gagliardi, G. Serra, T. Mongini, G. Siciliano
{"title":"SARS-CoV-2大流行突显的神经肌肉疾病的脆弱性和关键问题:有多少患者仍然“隐形”?","authors":"G. Ricci, F. Torri, F. Bianchi, L. Fontanelli, E. Schirinzi, Elisa Gualdani, P. Francesconi, Delia Gagliardi, G. Serra, T. Mongini, G. Siciliano","doi":"10.36185/2532-1900-065","DOIUrl":null,"url":null,"abstract":"Almost 90% of neuromuscular diseases (NMDs) are classified as rare diseases, defined as conditions affecting less than 5 individuals in 10.000 (0.05%). Their rarity and diversity pose specific challenges for healthcare and research. Epidemiological data on NMDs are often lacking and incomplete. The COVID-19 pandemic has further highlighted the management difficulties of NMDs patients and the necessity to continue the program of implementation of standard of care. This article summarizes the Italian experience during pandemic.","PeriodicalId":93851,"journal":{"name":"Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology","volume":"102 1","pages":"24-29"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still \\\"invisible\\\"?\",\"authors\":\"G. Ricci, F. Torri, F. Bianchi, L. Fontanelli, E. Schirinzi, Elisa Gualdani, P. Francesconi, Delia Gagliardi, G. Serra, T. Mongini, G. Siciliano\",\"doi\":\"10.36185/2532-1900-065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Almost 90% of neuromuscular diseases (NMDs) are classified as rare diseases, defined as conditions affecting less than 5 individuals in 10.000 (0.05%). Their rarity and diversity pose specific challenges for healthcare and research. Epidemiological data on NMDs are often lacking and incomplete. The COVID-19 pandemic has further highlighted the management difficulties of NMDs patients and the necessity to continue the program of implementation of standard of care. This article summarizes the Italian experience during pandemic.\",\"PeriodicalId\":93851,\"journal\":{\"name\":\"Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology\",\"volume\":\"102 1\",\"pages\":\"24-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36185/2532-1900-065\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36185/2532-1900-065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"?
Almost 90% of neuromuscular diseases (NMDs) are classified as rare diseases, defined as conditions affecting less than 5 individuals in 10.000 (0.05%). Their rarity and diversity pose specific challenges for healthcare and research. Epidemiological data on NMDs are often lacking and incomplete. The COVID-19 pandemic has further highlighted the management difficulties of NMDs patients and the necessity to continue the program of implementation of standard of care. This article summarizes the Italian experience during pandemic.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
